Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.2500 (0%) ($14.8100 - $15.5000) on Thu. Dec. 28, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.98% (three month average) | RSI | 77 | Latest Price | $15.2500(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(50%) IWO(49%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.49% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-12%) UNG(-3%) TIP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.49% (StdDev 2.98%) | Hourly BBV | 0 () | Intraday Trend | -0.7% | | | |
|
5 Day Moving Average | $15.37(-0.78%) | 10 Day Moving Average | $15.12(0.86%) | 20 Day Moving Average | $14.76(3.32%) | To recent high | -11.8% | To recent low | 15.5% | Market Cap | $1.133b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |